a级黄色片免费播放_亚洲色最新高清av网站_午夜天堂AV免费在线观看_五月天婷亚洲天综合网手机

159-2642-3062 027-65317797
服務(wù)熱線（工作日：9:00-17:30）

瀏覽量: 89

  • 產(chǎn)品名稱(chēng)： Research Grade Ocaratuzumab ( 奧卡妥珠單抗 )
  • 產(chǎn)品貨號(hào)： CSD00293
  • 貨期： 現(xiàn)貨
  • 價(jià)格與訂購(gòu)： 2480
  • 數(shù)量：
    庫(kù)存： 100
  • 規(guī)格： 100μg
  • 產(chǎn)品信息
  • 如何訂購(gòu)
    貨號(hào)（Catalog No.）
    CSD00293
    通用名INN
    Ocaratuzumab
    純度(Purity)
    >95%
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    別名(Alternative names)
    AME-133v,LY2469298
    靶點(diǎn);物種(Specificity target name;species)
    MS4A1/CD20[Homo sapiens]
    活性研究（體外/體內(nèi)研究）(Activity in vitro)
    Complement-dependent cytotoxicity(CDC), complement-dependent cellular cytotoxicity(CDCC), antibody-dependent cytotoxicity (ADCC) as well as the induction of apoptosis have been claimed to be responsible for the efficacy of rituximab. Rituximab can induce death of malignant B cell lines in vitro. Th strength of this effect varies considerably between target cell lines. Changes that have been identified in response to rituximab in vitro include inhibition of p38 mitogen-activated protein kinase, NF-κB, extracellular signal-regulated kinase 1/2 (ERK 1/2) and AKT antiapoptotic survival pathways. Rituximab is highly efficient at mediating CMC(complement dependent cytotoxicity) of various B cell lines as well as fresh malignant B cell samples. CD20-binding capacity of rituximab is dose-dependentv.
    種類(lèi)(Species)
    Humanized
    受體鑒定(Receptor identification)
    IgG1-kappa
    CAS
    1169956-08-4
    存儲(chǔ)條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .